Peptide with osteogenic activity

Patent Number: 7,163,920

This patent discloses a novel peptide that is capable of inducing osteoblast proliferation and induction of bone synthesis. The peptide disclosed may be used as part of an implantable composition of cells and biodegradable matrices for the treatment of bone fractures.

The patent covers numerous methods of making the peptide, as well as chemical derivatives and methods of administration.

Ethicon, the assignee company has been a pioneer in the area of bone repair using stem cells, as well as the combination of stem cells with extracellular matrix components for acceleration of healing.

View this patent on the USPTO website.